141 related articles for article (PubMed ID: 33301022)
21. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
22. Selecting a BRCA risk assessment model for use in a familial cancer clinic.
Panchal SM; Ennis M; Canon S; Bordeleau LJ
BMC Med Genet; 2008 Dec; 9():116. PubMed ID: 19102775
[TBL] [Abstract][Full Text] [Related]
23. Performance of BRCA1/2 mutation prediction models in male breast cancer patients.
Moghadasi S; Grundeken V; Janssen LAM; Dijkstra NH; Rodríguez-Girondo M; van Zelst-Stams WAG; Oosterwijk JC; Ausems MGEM; Oldenburg RA; Adank MA; Blom EW; Ruijs MWG; van Os TAM; van Deurzen CHM; Martens JWM; Schroder CP; Wijnen JT; Vreeswijk MPG; van Asperen CJ
Clin Genet; 2018 Jan; 93(1):52-59. PubMed ID: 28589637
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
25. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Sardanelli F; Podo F; Santoro F; Manoukian S; Bergonzi S; Trecate G; Vergnaghi D; Federico M; Cortesi L; Corcione S; Morassut S; Di Maggio C; Cilotti A; Martincich L; Calabrese M; Zuiani C; Preda L; Bonanni B; Carbonaro LA; Contegiacomo A; Panizza P; Di Cesare E; Savarese A; Crecco M; Turchetti D; Tonutti M; Belli P; Maschio AD;
Invest Radiol; 2011 Feb; 46(2):94-105. PubMed ID: 21139507
[TBL] [Abstract][Full Text] [Related]
26. Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
BMJ Open; 2021 Apr; 11(4):e045078. PubMed ID: 33846154
[TBL] [Abstract][Full Text] [Related]
27. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
28. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
[TBL] [Abstract][Full Text] [Related]
29. Prospective Evaluation over 15 Years of Six Breast Cancer Risk Models.
Li SX; Milne RL; Nguyen-Dumont T; English DR; Giles GG; Southey MC; Antoniou AC; Lee A; Winship I; Hopper JL; Terry MB; MacInnis RJ
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680343
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
[TBL] [Abstract][Full Text] [Related]
31. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
[TBL] [Abstract][Full Text] [Related]
33. The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography?
Gui GP; Hogben RK; Walsh G; A'Hern R; Eeles R
Eur J Cancer; 2001 Sep; 37(13):1668-73. PubMed ID: 11527694
[TBL] [Abstract][Full Text] [Related]
34. Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models.
Ming C; Viassolo V; Probst-Hensch N; Chappuis PO; Dinov ID; Katapodi MC
Breast Cancer Res; 2019 Jun; 21(1):75. PubMed ID: 31221197
[TBL] [Abstract][Full Text] [Related]
35. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
Banegas MP; John EM; Slattery ML; Gomez SL; Yu M; LaCroix AZ; Pee D; Chlebowski RT; Hines LM; Thompson CA; Gail MH
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 28003316
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the performance of National Comprehensive Cancer Network (NCCN) breast and ovarian genetic/familial high risk assessment referral criteria for breast cancer women in an Asian surgical breast clinic.
Lim GH; Borje E; Allen JC
Gland Surg; 2017 Feb; 6(1):35-42. PubMed ID: 28210550
[TBL] [Abstract][Full Text] [Related]
37. Validation of two US breast cancer risk prediction models in German women.
Hüsing A; Quante AS; Chang-Claude J; Aleksandrova K; Kaaks R; Pfeiffer RM
Cancer Causes Control; 2020 Jun; 31(6):525-536. PubMed ID: 32253639
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
39. Use of detailed family history data to improve risk prediction,with application to breast cancer screening.
Jiang Y; Weinberg CR; Sandler DP; Zhao S
PLoS One; 2019; 14(12):e0226407. PubMed ID: 31846476
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
